日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis

图卡替尼联合曲妥珠单抗治疗化疗难治性、HER2阳性、RAS野生型转移性结直肠癌(MOUNTAINEER研究):最终分析

Strickler, John H; Cercek, Andrea; Siena, Salvatore; André, Thierry; Ng, Kimmie; Van Cutsem, Eric; Wu, Christina; Paulson, Andrew Scott; Hubbard, Joleen M; Coveler, Andrew L; Fountzilas, Christos; Kardosh, Adel; Kasi, Pashtoon Murtaza; Lenz, Heinz-Josef; Ciombor, Kristen; Elez, Elena; Bajor, David L; Cremolini, Chiara; Sanchez, Federico; Nayeri, Mina; Feng, Wentao; Bieda, Mark; Bekaii-Saab, Tanios S

Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer

一名晚期复发性转移性错配修复功能正常/微卫星稳定(pMMR/MSS)直肠癌患者接受RIN方案(瑞戈非尼、伊匹木单抗和纳武利尤单抗)治疗后获得分子完全缓解

Qadri, Fatima; Afghan, Maaz Khan; Lutfi, Areeb; Javaid, Sana; Guniganti, Preethi; Cardenes, Higinia; Pigazzi, Alessio; Kasi, Pashtoon Murtaza

Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results

靶向淋巴结的mKRAS特异性两亲性疫苗治疗胰腺癌和结直肠癌:AMPLIFY-201 I期试验最终结果

Zev A Wainberg ,Colin D Weekes ,Muhammad Furqan ,Pashtoon M Kasi ,Craig E Devoe ,Alexis D Leal ,Vincent Chung ,James R Perry ,Thian Kheoh ,Lisa K McNeil ,Esther Welkowsky ,Peter C DeMuth ,Christopher M Haqq ,Shubham Pant # ,Eileen M O'Reilly #

Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma

一项针对既往未接受治疗的HER2扩增转移性胃食管腺癌患者的II期研究,评估avelumab和trastuzumab联合FOLFOX化疗的疗效。

Lee, Michael S; Chao, Joseph; Mulcahy, Mary F; Kasi, Pashtoon M; Alistar, Angela T; Mukherjee, Sarbajit; Akce, Mehmet; Moore, Dominic T; McRee, Autumn J; Somasundaram, Ashwin

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial

淋巴结靶向、mKRAS特异性两亲性疫苗在胰腺癌和结直肠癌中的应用:AMPLIFY-201 I期试验

Shubham Pant ,Zev A Wainberg ,Colin D Weekes ,Muhammad Furqan ,Pashtoon M Kasi ,Craig E Devoe ,Alexis D Leal ,Vincent Chung ,Olca Basturk ,Haley VanWyk ,Amy M Tavares ,Lochana M Seenappa ,James R Perry ,Thian Kheoh ,Lisa K McNeil ,Esther Welkowsky ,Peter C DeMuth ,Christopher M Haqq ,Eileen M O'Reilly

Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types

循环肿瘤DNA能够灵敏地检测各种癌症类型中可靶向的基因融合和重排

Kasi, Pashtoon M; Lee, Jessica K; Pasquina, Lincoln W; Decker, Brennan; Vanden Borre, Pierre; Pavlick, Dean C; Allen, Justin M; Parachoniak, Christine; Quintanilha, Julia C F; Graf, Ryon P; Schrock, Alexa B; Oxnard, Geoffrey R; Lovly, Christine M; Tukachinsky, Hanna; Subbiah, Vivek

Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid Tumors

下一代测序评估微卫星不稳定性与实体瘤免疫组化-错配修复的一致性分析

Ali-Fehmi, Rouba; Krause, Harris Benjamin; Morris, Robert T; Wallbillich, John J; Corey, Logan; Bandyopadhyay, Sudeshna; Kheil, Mira; Elbashir, Leana; Zaiem, Fadi; Quddus, M Ruhul; Abada, Evi; Herzog, Thomas; Karnezis, Anthony N; Antonarakis, Emmanuel S; Kasi, Pashtoon Murtaza; Wei, Shuanzeng; Swensen, Jeffrey; Elliott, Andrew; Xiu, Joanne; Hechtman, Jaclyn; Spetzler, David; Abraham, Jim; Radovich, Milan; Sledge, George; Oberley, Matthew J; Bryant, David

Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary

通过整合 92 基因检测的分子癌症分类和肿瘤分析,为原发灶不明的癌症患者提供个性化治疗选择

Harry E Fuentes Bayne, Pashtoon M Kasi, Li Ma, Lowell L Hart, Jenna Wong, David R Spigel, Catherine A Schnabel, James A Reeves, Thorvardur R Halfdanarson, Kai Treuner, F Anthony Greco

8 Nivolumab plus ipilimumab vs sunitinib for first-line treatment of advanced renal cell carcinoma: 8-year follow-up with analyses in favorable risk patients from the phase 3 CheckMate 214 trial

8. 纳武利尤单抗联合伊匹木单抗对比舒尼替尼一线治疗晚期肾细胞癌:来自3期CheckMate 214试验的8年随访及对预后良好患者的分析

Brar, Gagandeep; Kasi, Pashtoon Murtaza; Saliby, Renee Maria; Xie, Wanling; Wells, Connor J; Saad, Eddy; Eid, Marc; Semaan, Karl; Labaki, Chris; Ferrier, Evan; Zarba, Martin; Ebrahimi, Hedyeh; Ravi, Praful; Suarez, Cristina; Morales, Jose Ruiz; McKay, Rana R; Powles, Thomas; Wood, Lori; Lalani, Aly-Khan A; Pal, Sumanta K; de Velasco, Guillermo; Takemura, Kosuke; Agarwal, Neeraj; Braun, David A; Heng, Daniel Y; Choueiri, Toni K; Atkins, Michael B; Escudier, Bernard; McDermott, David F; Burotto, Mauricio; Choueiri, Toni K; Hammers, Hans J; Plimack, Elizabeth R; Porta, Camillo; George, Saby; Powles, Thomas; Donskov, Frede; Kollmannsberger, Christian K; Grimm, Marc-Oliver; Tomita, Yoshihiko; Rini, Brian I; Jiang, Ruiyun; Federov, Viktor; Lee, Chung-Wei; Desilva, Heshani; Tannir, Nizar M; Motzer, Robert J

Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma

个性化和肿瘤信息ctDNA与胰腺腺癌患者生存结局的相关性

Botta, Gregory P; Abdelrahim, Maen; Drengler, Ronald L; Aushev, Vasily N; Esmail, Abdullah; Laliotis, George; Brewer, Chris M; George, Giby V; Abbate, Steven M; Chandana, Sreenivasa R; Tejani, Mohamedtaki A; Malla, Midhun; Bansal, Dhruv; Rivero-Hinojosa, Samuel; Spickard, Erik; McCormick, Nicole; Cecchini, Michael; Lacy, Jill; Fei, Naomi; Kasi, Pashtoon Murtaza; Kasi, Anup; Dayyani, Farshid; Hanna, Diana L; Sharma, Shruti; Malhotra, Meenakshi; Aleshin, Alexey; Liu, Minetta C; Jurdi, Adham